Ivanov et al., 2016 - Google Patents
In vitro models of medulloblastoma: Choosing the right tool for the jobIvanov et al., 2016
View HTML- Document ID
- 5216841387698034465
- Author
- Ivanov D
- Coyle B
- Walker D
- Grabowska A
- Publication year
- Publication venue
- Journal of biotechnology
External Links
Snippet
The recently-defined four molecular subgroups of medulloblastoma have required updating of our understanding of in vitro models to include molecular classification and risk stratification features from clinical practice. This review seeks to build a more comprehensive …
- 208000000172 Medulloblastoma 0 title abstract description 128
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ivanov et al. | In vitro models of medulloblastoma: Choosing the right tool for the job | |
| Mao et al. | Type IV collagens and basement membrane diseases: cell biology and pathogenic mechanisms | |
| Phinney et al. | Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at US academic centers | |
| An et al. | Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells | |
| Na et al. | Aneuploidy in pluripotent stem cells and implications for cancerous transformation | |
| Melo et al. | Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant | |
| Higuchi et al. | Generation of pluripotent stem cells without the use of genetic material | |
| WO2015200805A8 (en) | Methods and compositions for targeted genetic modifications and methods of use | |
| MX2018001617A (en) | Engineered crispr-cas9 compositions and methods of use. | |
| WO2010124200A3 (en) | Genetically modified rat models for cancer | |
| MX2012000455A (en) | Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions. | |
| MY156588A (en) | Systems using cell culture for production of isoprene | |
| MX2020009670A (en) | Perfusion culturing methods and uses thereof. | |
| MX353134B (en) | Genetically modified t cell receptor mice. | |
| TW200730623A (en) | Reprogramming and genetic modification of cells | |
| WO2011011678A3 (en) | Genetically modified rat models for cytokine-cytokine signaling pathways | |
| EP4219739A3 (en) | Polymerase compositions, methods of making and using same | |
| BR112014027378A2 (en) | high-yield transient expression in mammalian cells using unique high density growth-matched transfection medium and expression enhancers | |
| WO2011103343A3 (en) | Methods for telomere length and genomic dna quality control analysis in pluripotent stem cells | |
| MX2019015321A (en) | Three dimensional tissue compositions and methods of use. | |
| WO2010031074A3 (en) | Compositions and methods for regulating cell osmolarity | |
| NZ586957A (en) | Cell lines and methods for making and using them | |
| BR112013018744A2 (en) | method for producing a recombinant polypeptide or protein | |
| WO2015108944A3 (en) | Stem cell-derived hepatocytes in co-culture and uses thereof | |
| NZ599479A (en) | Improved reverse genetics methods for virus rescue |